Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 3 | 2025 | 1028 | 0.940 |
Why?
|
| Methylprednisolone | 1 | 2025 | 90 | 0.890 |
Why?
|
| Thrombosis | 3 | 2023 | 494 | 0.780 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 295 | 0.760 |
Why?
|
| Venous Thromboembolism | 2 | 2023 | 165 | 0.740 |
Why?
|
| Thrombophilia | 1 | 2021 | 39 | 0.700 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2019 | 49 | 0.690 |
Why?
|
| Blood Coagulation | 1 | 2021 | 123 | 0.680 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 189 | 0.640 |
Why?
|
| Balloon Valvuloplasty | 1 | 2020 | 22 | 0.640 |
Why?
|
| Carotid Artery Injuries | 1 | 2018 | 33 | 0.560 |
Why?
|
| Inflammation | 1 | 2025 | 1428 | 0.540 |
Why?
|
| Head and Neck Neoplasms | 2 | 2013 | 566 | 0.540 |
Why?
|
| Aneurysm, False | 1 | 2018 | 71 | 0.520 |
Why?
|
| Ventricular Function, Left | 1 | 2020 | 503 | 0.500 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 318 | 0.490 |
Why?
|
| Tetralogy of Fallot | 1 | 2018 | 173 | 0.490 |
Why?
|
| Heart Ventricles | 1 | 2019 | 748 | 0.450 |
Why?
|
| Tranexamic Acid | 2 | 2025 | 31 | 0.430 |
Why?
|
| Antifibrinolytic Agents | 2 | 2025 | 47 | 0.420 |
Why?
|
| Laryngeal Muscles | 1 | 2013 | 5 | 0.410 |
Why?
|
| Spasm | 1 | 2013 | 44 | 0.400 |
Why?
|
| Dysphonia | 1 | 2013 | 16 | 0.400 |
Why?
|
| Cultural Diversity | 1 | 2013 | 73 | 0.390 |
Why?
|
| Heart Transplantation | 1 | 2019 | 857 | 0.390 |
Why?
|
| Lymphangioma | 1 | 2012 | 23 | 0.380 |
Why?
|
| Sclerotherapy | 1 | 2012 | 36 | 0.370 |
Why?
|
| Lymphatic Abnormalities | 1 | 2012 | 34 | 0.360 |
Why?
|
| Doxycycline | 1 | 2012 | 119 | 0.360 |
Why?
|
| Lung Diseases | 2 | 2025 | 391 | 0.330 |
Why?
|
| Retrospective Studies | 10 | 2025 | 16725 | 0.300 |
Why?
|
| Papillomavirus Infections | 1 | 2013 | 381 | 0.300 |
Why?
|
| Anticoagulants | 3 | 2023 | 558 | 0.290 |
Why?
|
| Survival Rate | 1 | 2013 | 2041 | 0.290 |
Why?
|
| Pregnancy Complications | 1 | 2013 | 537 | 0.280 |
Why?
|
| Heart Defects, Congenital | 1 | 2020 | 1838 | 0.280 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2025 | 665 | 0.270 |
Why?
|
| Hemorrhage | 3 | 2025 | 466 | 0.260 |
Why?
|
| Infant | 6 | 2025 | 12758 | 0.250 |
Why?
|
| Child | 10 | 2025 | 25015 | 0.230 |
Why?
|
| Warfarin | 2 | 2023 | 109 | 0.200 |
Why?
|
| Child, Preschool | 5 | 2025 | 14316 | 0.200 |
Why?
|
| Male | 9 | 2025 | 61966 | 0.190 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 110 | 0.190 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 437 | 0.190 |
Why?
|
| Treatment Outcome | 5 | 2025 | 12334 | 0.180 |
Why?
|
| Adolescent | 5 | 2025 | 19904 | 0.180 |
Why?
|
| Female | 10 | 2025 | 67790 | 0.180 |
Why?
|
| Humans | 15 | 2025 | 125613 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2021 | 65 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 200 | 0.160 |
Why?
|
| Postoperative Period | 1 | 2021 | 322 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2021 | 312 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 484 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2022 | 8362 | 0.140 |
Why?
|
| Device Removal | 1 | 2019 | 217 | 0.140 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2018 | 114 | 0.140 |
Why?
|
| Angiography | 1 | 2018 | 182 | 0.140 |
Why?
|
| Echocardiography | 2 | 2020 | 1095 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 351 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 421 | 0.120 |
Why?
|
| Graft Rejection | 1 | 2019 | 554 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2019 | 800 | 0.120 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 1119 | 0.110 |
Why?
|
| Voice Quality | 1 | 2013 | 20 | 0.100 |
Why?
|
| Speech | 1 | 2013 | 56 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2023 | 2974 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2023 | 1289 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 9556 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 1521 | 0.070 |
Why?
|
| Adult | 2 | 2019 | 30189 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1973 | 0.060 |
Why?
|
| Administration, Inhalation | 1 | 2025 | 184 | 0.050 |
Why?
|
| Factor IX | 1 | 2023 | 15 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5079 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2023 | 22 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2023 | 31 | 0.050 |
Why?
|
| Hirudins | 1 | 2022 | 35 | 0.050 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 238 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 47 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 124 | 0.050 |
Why?
|
| Heparin | 1 | 2022 | 203 | 0.040 |
Why?
|
| Pregnancy | 1 | 2013 | 7391 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 526 | 0.040 |
Why?
|
| Ventricular Function, Right | 1 | 2019 | 113 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2022 | 742 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 2757 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6020 | 0.020 |
Why?
|